Thursday

22nd Oct 2020

Coronavirus

EU wants to pay in advance for promising vaccines

  • In an effort to find a successful vaccine fast, companies are building up production and trying promising drugs at the same time (Photo: Hospital Clínic)

The EU Commission wants member states' support to pay some of the costs upfront for companies working on potential Covid-19 vaccines and secure doses for European citizens.

Under its "vaccine strategy" to be presented next Wednesday (17 June), the EU executive plans to sign contracts with pharmaceutical companies working on possible vaccines on behalf of the 27 member states.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

EU health ministers will discuss the plans with the commission when they meet on Friday (12 June).

The commission argued it makes more sense for EU countries to negotiate together rather than in parallel and possibly in competition with one another with firms to secure a vaccine and supply for citizens.

The commission and EU countries' experts would negotiate with companies and agree in an advance payment that firms could use to upgrade their production facilities and look for raw material, even as trials for potential vaccines are still ongoing.

In preliminary talks, companies have told the commission they need public authorities to help "derisk the investment" in potential vaccines.

In order to secure a successful vaccine fast, companies need to build capacities at the same time as they put potential vaccines through trials that eventually might or might not be successful.

The EU would help with those costs, and take that risk, in exchange for commitment from these companies to provide the vaccine to the EU when it is successful and ready.

"We provide funding, they invest, prepare the vaccine, and if successful, they give it to us, with the risk that some of of the potential vaccines we invest in won't work," a commission official said.

Ultimately, the member states would be buying the vaccines and governments would decide on who gets access to the drug first, with most likely health care and frontline workers getting vaccinated first.

The commission aims at signing contracts with several companies to hedge bets. For now it has set aside €2.7bn from the EU budget for advanced payments.

'Contract, not subsidy'

"We are not talking here about subsidies to companies, we are talking about contracting for the vaccine, reflecting the cost of producing it," the commission official said.

The executive will be looking at companies that have the potential to develop the drug fast, whose vaccine has already entered the clinical trials phase or is very close to that.

The commission is also looking for companies that have a very strong production capacity in Europe. "We look at production facility, not the nationality of company," the commission official added.

The official said the EU needs to secure around 300-600 million doses of the vaccine depending on how many doses are needed per person for immunisation.

The EU executive also proposes temporarily lifting the requirement to have an environmental risk assessment on possible GMOs used to develop the vaccine, because it would delay the process. But the member states and the EU parliament need to agree to this move.

Recently, an "alliance" between Germany, France, Italy and the Netherlands was also forged to fund and secure vaccine for Europeans.

The commission official said they are not competing with the alliance and, within a matter of days, they will work out how to combine their efforts.

Once member states agree to task the commission with negotiating with companies, the EU countries could not negotiate themselves with the same companies, but could contract firms that have not signed agreements with the EU executive.

EU launches funding drive for Covid-19 vaccine

The European Commission launches on Monday an initiative to raise €7.5bn to speed up the development of vaccines, treatment and testing capacity, ensuring that is equally "available to everyone and at affordable prices" and avoiding nationalisms.

EU Commission ready to play bigger role in health sector

The public health crisis caused by the coronavirus in member states has pushed the European Commission to play a more active in the field of health, especially funding the development of an effective Covid-19 vaccine.

How EU aims - hopefully - to secure vaccine by end of 2020

The European Commission hopes to have 30m doses of AstraZeneca's potential coronavirus vaccine before the end of this year, to be distributed on a population-based pro-rata basis among the 27 EU countries - until the 300m doses negotiated arrive.

News in Brief

  1. Commission to press Croatia on migrant 'abuse' at border
  2. Belarus opposition awarded 2020 Sakharov Prize
  3. Belgium's foreign minister in intensive care for Covid-19
  4. MEPs restrict CAP funding for bullfighting
  5. Coronavirus: Liège is 'the Lombardy of the second wave'
  6. UK to keep out EU nationals with criminal past
  7. Report: EU to restrict travel from Canada, Tunisia, Georgia
  8. Pope Francis supports same-sex civil unions

EU tries to avoid lockdowns as global death toll reaches 1m

Several member states are putting forward restrictive Covid-19-related measures to try to control the surge of numbers of coronavirus cases, trying to avoid a second lockdown. Meanwhile, the global death toll from the novel coronavirus has reached one million.

Stakeholders' Highlights

  1. UNESDAMaking healthier diets the easy choice
  2. Nordic Council of MinistersUN Secretary General to meet with Nordic Council on COVID-19
  3. UNESDAWell-designed Deposit Return Schemes can help reach Single-Use Plastics Directive targets
  4. Nordic Council of MinistersNordic Council meets Belarusian opposition leader Svetlana Tichanovskaja
  5. Nordic Council of MinistersNordic Region to invest DKK 250 million in green digitalised business sector
  6. UNESDAReducing packaging waste – a huge opportunity for circularity

Latest News

  1. Nato and EU silent on Turkey, despite Armenia's appeal
  2. EU tells UK to decide on Brexit as deal 'within reach'
  3. EU farming deal attacked by Green groups
  4. France vows tough retaliation for teacher's murder
  5. All eyes on EU court for decision on religious slaughter
  6. 'Big majority' of citizens want EU funds linked to rule of law
  7. EU declares war on Malta and Cyprus passport sales
  8. EU Commission's Libya stance undercut by internal report

Join EUobserver

Support quality EU news

Join us